Fractionated dosage of radioiodine for the ablation of differentiated thyroid carcinoma

Thyroid

Volumn 15, Issue 11, 2005, Pages 1261-1265

  Czepczyński, Rafał ^a   Ziemnicka, Katarzyna ^a   Ba̧czyk, Maciej ^a   Oleksa, Robert ^a   Ruchała, Marek ^a   Sowiński, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; THYROID CARCINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARCINOMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; TREATMENT OUTCOME; WHOLE-BODY COUNTING;

EID: 29244450837     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1261     Document Type: Article

References (33)

1. Mazzaferri EL 1999 NNCN Thyroid carcinoma practice guidelines. Oncology 13:391-442.
2. Feld S 1997 AACE Clinical practice guidelines for the management of thyroid carcinoma. Endocr Practice 3:61-70.
3. 131I ablation for papillary and follicular thyroid carcinoma. Thyroid 7:265-271.
4. British Thyroid Association. Royal College of Physicians 2002 Guidelines for the management of thyroid cancer in adults. Sarum ColourView Group, Salisbury, UK.
5. American Association of Clinical Endocrinologists 2001 American College of Endocrinology 2001 AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 7:202-220.
6. Jarzab B, Gembicki M, Herman K, Kinalska I, Królicki L, Kulig A, Kułekowski A, Lewiński A, Maciejewski B, Nauman J, Olszewski W, Pomorski L, Reinfuss M, Rybiński K, Sowiński J, Stachura J, Steifen J, Szybiński Z 2000 Recommendations of the Scientific Committee of the 2nd Conference, "Thyroid Carcinoma" Szczyrk, Poland.
7. 131I outpatient therapy. J Nucl Med Technol 30:165-171.
8. Hung GU, Tu ST, Wu IS, Yang KT 2004 Comparison of the effectiveness between a single low dose and fractionated dose of radioiodine in ablation of post-operative thyroid remnants. Jps J Clin Oncol 34:469-171.
9. Coackley AJ 1998 Thyroid stunning. Eur J Nucl Med 25:203-204.
10. Leger FA, Izembart M, Dagousset F, Barritault L, Baillet Gm Chevalier A, Clerc J 1988 Decreased uptake of therapeutic doses of iodine-131 after 185 MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med 25:242-246.
11. Muratet JP, Daver A, Minier JF, Larra F 1998 Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med 39:1546-1550.
12. Arad E, Flannery K, Wilson GA, O'Mara RE 1990 Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants. Clin Nucl Med 15:676-677.
13. Wang SJ, Liu TJ 2002 Use of fractionated doses of iodine-131 for ablation of thyroid remnants. Zhonghua Yi Xue Za Zhi (Taipei) 65:336-340.
14. Chanoine JP, Toppet V, Lagasse R, Spehl M, Delange F 1991 Determination of thyroid volume by ultrasound from the neonatal period to late adolescence. Eur J Pediatr 150:395-399.
15. Rawson RW, Rall JE, Peacock W 1951 Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine. J Clin Endocrinol 11:1128-1142.
16. Jeevanram RK, Shah DH, Sharma SM, Ganatra RD 1986 Influence of large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol 13:277-279.
17. Huic D, Medvedec M, Dodig D, Popovic S, Ivancevic D, Pavlinovic Z, Zuvic M 1996 Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose I-131. Nucl Med Commun 17:839-842.
18. Maxon HR, Enlargo E, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD 1992 Radioiodine-131 therapy for well-differentiated thyroid cancer-a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 32:1132-1136.
19. Behr TM, Behe MP, Gratz S, Hufner M, Becker W 2001 Factors influencing the dosimetry and the therapeutic outcome of I-131 therapy of differentiated thyroid cancer (DTC) [abstract]. J Nucl Med 42 (Suppl):242.
20. Sinyuta B, Dzhuzha D 2001 The influence of diagnostic radiation absorbed doses and time interval on the degree of thyroid stunning [abstract]. Eur J Nucl Med 28:1004.
21. 131I. Eur J Nucl Med 29:1421-1427.
22. Park HM, Park YH, Zhou XH 1997 Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma. Thyroid 7:277-280.
23. 131I (i.e. does not cause stunning) in differentiated thyroid cancer. Nucl Med Commun 18:505-512.
24. Yeung HWD, Humm JL, Larson SM 2000 Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry. J Nucl Med 41:1082-1085.
25. Koch W, Knesewitsch P, Tatsch K, Hahn K 2003 Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out. Nuklearmedizin 42:10-14.
26. 131I-scanned and nonscanned individuals. J Clin Endocrinol Metab 86:3507-3511.
27. 131I. J Nucl Med 41:1198-1202.
28. 123I. Eur J Nucl Med 29:783-788.
29. Modoni S, Martino G, Valle G, Perrone E, Frusciante V 2000 How is thyroid remnant ablation affected by former 131-I diagnostic doses and/or elapsed time? Eur J Nucl Med 27:1152.
30. Wu HS, Hseu HH, Lin WY, Wang SJ, Liu YC 2005 Decreased uptake after fractionated ablative doses of iodine-131. Eur J Nucl Med Mol Imaging 32:167-173.
31. Bal CS, Kumar A, Pant GS 2004 Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. J Clin Endocrinol Metab 89:1666-1673.
32. Tuttle WK, Brown PH 2000 Applying nuclear regulatory commission guidelines to the release of patients treated with sodium iodine-131. J Nucl Med Technol 28:275-279.
33. Barrington SF, Kettle AG, O'Doherty MJ, Wells CP, Somer EJ, Coackley AJ 1996 Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med 23:123-130.